Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy

Colloids and Surfaces. B, Biointerfaces
Josimar Oliveira EloyJuliana Maldonado Marchetti

Abstract

Paclitaxel and rapamycin have been reported to act synergistically to treat breast cancer. Albeit paclitaxel is available for breast cancer treatment, the most commonly used formulation in the clinic presents side effects, limiting its use. Furthermore, both drugs present pharmacokinetics drawbacks limiting their in vivo efficacy and clinic combination. As an alternative, drug delivery systems, particularly liposomes, emerge as an option for drug combination, able to simultaneously deliver co-loaded drugs with improved therapeutic index. Therefore, the purpose of this study is to develop and characterize a co-loaded paclitaxel and rapamycin liposome and evaluate it for breast cancer efficacy both in vitro and in vivo. Results showed that a SPC/Chol/DSPE-PEG (2000) liposome was able to co-encapsulate paclitaxel and rapamycin with suitable encapsulation efficiency values, nanometric particle size, low polydispersity and neutral zeta potential. Taken together, FTIR and thermal analysis evidenced drug conversion to the more bioavailable molecular and amorphous forms, respectively, for paclitaxel and rapamycin. The pegylated liposome exhibited excellent colloidal stability and was able to retain drugs encapsulated, which were releas...Continue Reading

References

Oct 1, 1994·Clinical Pharmacokinetics·D S Sonnichsen, M V Relling
Jan 10, 1998·Journal of Pharmaceutical Sciences·R T LigginsH M Burt
Jan 21, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·P CrosassoL Cattel
Aug 29, 2001·Clinical Pharmacokinetics·K Mahalati, B D Kahan
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wallace H MondesireFunda Meric-Bernstam
Nov 30, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·J Allen ZhangImran Ahmad
Mar 21, 2007·International Journal of Pharmaceutics·Tao YangDae-Duk Kim
Jun 26, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tao YangDae-Duk Kim
Apr 15, 2011·Journal of Drug Delivery·Andreas Wagner, Karola Vorauer-Uhl
Apr 22, 2011·International Journal of Pharmaceutics·Yuta YoshizawaKazutaka Higaki
Jun 3, 2011·Molecular Pharmaceutics·Ho-Chul ShinGlen S Kwon
Aug 17, 2012·Molecular Cancer Therapeutics·Jason R HasensteinKevin R Kozak
Sep 20, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Stěpán Koudelka, Jaroslav Turánek
Oct 6, 2012·Advanced Drug Delivery Reviews·Theresa M Allen, Pieter R Cullis
Oct 17, 2012·AAPS PharmSciTech·Josimar de Oliveira EloyJuliana Maldonado Marchetti
Oct 24, 2012·International Journal of Pharmaceutics·Huey Minn TeowAntony D'Emanuele
Jul 16, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Joanna KopeckaChiara Riganti
Feb 27, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elvin BlancoMauro Ferrari
Apr 16, 2014·Journal of Nanoscience and Nanotechnology·Sudipta Mallick, Joon Sig Choi
Jun 24, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yuta YoshizawaKazutaka Higaki
Jul 20, 2014·Carbohydrate Polymers·Meng-Xia ChenDai-Yin Peng
Sep 6, 2014·Breast Cancer Research : BCR·Cecile VicierFabrice Andre
Oct 5, 2014·Colloids and Surfaces. B, Biointerfaces·Josimar Oliveira EloyJuliana Maldonado Marchetti
Feb 18, 2015·Breast Cancer Research and Treatment·Carlos Acevedo-GadeaMaysa M Abu-Khalaf
Jun 21, 2015·International Journal of Biological Macromolecules·Jaber EmamiNeal Davies
Nov 23, 2015·Colloids and Surfaces. B, Biointerfaces·Marco PainiPeter Valtchev

❮ Previous
Next ❯

Citations

Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·DongMei YuBin Zhang
Dec 1, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Azadeh HaeriSimin Dadashzadeh
Aug 19, 2017·Nanoscale Research Letters·Maria MirFakhar Ud Din
Jul 18, 2018·Oxidative Medicine and Cellular Longevity·Márcia Fernanda Correia Jardim PazJuliana da Silva
Dec 15, 2017·Critical Reviews in Analytical Chemistry·Renata Carolina AlvesMarlus Chorilli
Sep 29, 2019·Biomolecules·Shima TavakolAlan Prem Kumar
Apr 11, 2018·Cancer Biotherapy & Radiopharmaceuticals·Merve KarpuzAsuman Yekta Ozer
Nov 7, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Qin ShuQihe Chen
Mar 20, 2020·Current Pharmaceutical Design·Nafis HaiderMohammad A Khan
Sep 26, 2020·Frontiers in Molecular Biosciences·Yihan YaoAnwen Shao
Dec 22, 2020·Medicinal Research Reviews·Farideh OrdikhaniNasim Annabi
Dec 20, 2020·Journal of Pharmaceutical Sciences·Ravindra Dhar DubeyNarayan S Hosmane
Jun 24, 2020·Colloids and Surfaces. B, Biointerfaces·Josimar O EloyMarlus Chorilli
May 25, 2020·Journal of Pharmaceutical Sciences·Laishun XiSuming Li
May 26, 2021·Expert Opinion on Drug Delivery·Eder Lilia Romero, Maria Jose Morilla
May 26, 2020·Current Molecular Pharmacology·Deepak PradhanGoutam Rath
Nov 23, 2021·Pharmaceutical Development and Technology·Roshan KatekarJiaur R Gayen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.